Top Things to Know: Standardization of Collected Biobank Data to Facilitate Cardiovascular Research
Updated: October 19, 2026
Prepared by Andrew Landstrom, MD, PhD & Kayode Kuku, MBBS, Science and Medicine Advisor
- Cardiovascular biobanks are essential infrastructure for precision medicine, enabling the discovery of disease mechanisms, biomarkers, and precision therapies.
- Lack of standardization remains a major limitation in cardiovascular biobanking. Standardization of data collection, phenotype definitions, biospecimen handling, and consent practices is necessary to maximize the scientific value and enable cross-study collaboration.
- The value of biospecimens can be significantly enhanced when linked to deep longitudinal clinical, imaging, genomic, and outcomes data, enabling more comprehensive investigation of disease mechanisms and clinical trajectories.
- Cardiovascular biobanks have evolved from disease-specific repositories to large-scale population resources. Future cardiovascular discovery will depend on integrating multi-modal and multi-omics datasets, including genomic, clinical, imaging, environmental, and digital health data.
- High-quality biospecimen collection, processing, storage, and quality control are prerequisites for reliable and reproducible research.
- Common data models, interoperability, and data-sharing platforms are critical for enabling collaboration across institutions, health systems, and countries. Realizing these goals requires multidisciplinary partnerships among researchers, clinicians, ethicists, and policymakers.
- Robust governance, informed consent, privacy protections, and participant-centered stewardship must be incorporated into biobank design from the outset.
- Artificial intelligence and advanced analytics will play an increasingly important role in extracting meaningful insights from large-scale multimodal biobank datasets.
- Diverse participant populations and sustained longitudinal follow-up are essential to ensure findings are equitable, generalizable, and clinically meaningful.
- The ultimate measure of success for a cardiovascular biobank is its ability to translate discoveries into improved patient care and health outcomes.
Citation
Chahal CAA, Landstrom AP, Mohammed SF, Bouatia-Naji N, Kullo IJ, Martin CL, Petersen SE, Patel RS, Lindholm ME, Afifi N, Gaziano JM, Roden DM; on behalf of the American Heart Association Council on Genomic and Precision Medicine. Standardization of collected biobank data to facilitate cardiovascular research: a scientific statement from the Ameri-can Heart Association. Published online October 19, 2026. Circ Genom Precis Med. doi: 10.1161/HCG.0000000000000102